Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Lutz

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
The American Journal of Physiology|February 1, 1995
Disassembly of rat pancreatic acinar cell cytoskeleton during supramaximal secretagogue stimulationJ Jungermann, M M Lerch, H Weidenbach, et al.
The Journal of Biological Chemistry|June 5, 1993
Control of cholecystokinin receptor dephosphorylation in pancreatic acinar cellsM P Lutz, D I Pinon, L K Gates, et al.
Zeitschrift Fur Gastroenterologie|October 26, 2006
[ASCO update 2006--highlights of the 42. meeting of the American Society of Clinical Oncology/ASCO 2006]A Reinacher-Schick, D Arnold, F Lordick, et al.
Cancer Research|August 29, 1998
Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cellsB B Flossmann-Kast, P M Jehle, A Hoeflich, et al.
Cancer Research|April 20, 2001
Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell linesA Menke, C Philippi, R Vogelmann, et al.
The American Journal of Physiology|January 22, 1998
Protein tyrosine phosphorylation in pancreatic acini: differential effects of VIP and CCKM P Lutz, A Piiper, H Y Gaisano, et al.
Zeitschrift Fur Gastroenterologie|October 17, 2003
[ASCO Update 2003 - Highlights of the 39th Meeting of the American Society of Clinical Oncology/ASCO 2003]T Eberl, U Graeven, M Heike, et al.
Zeitschrift Fur Gastroenterologie|December 14, 2004
[ASCO update -- highlights of the 40th Meeting of the American Society of Clinical Oncology/ASCO 2004]U Graeven, M Heike, T Höhler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinomaG Folprecht, M P Lutz, P Schöffski, et al.
Zeitschrift Fur Gastroenterologie|November 5, 1999
A phase II study of weekly 24-h infusion of high-dose 5-fluorouracil in advanced pancreatic cancerM P Lutz, M Königer, R Muche, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
The American Journal of Physiology|February 1, 1995
Disassembly of rat pancreatic acinar cell cytoskeleton during supramaximal secretagogue stimulationJ Jungermann, M M Lerch, H Weidenbach, et al.
The Journal of Biological Chemistry|June 5, 1993
Control of cholecystokinin receptor dephosphorylation in pancreatic acinar cellsM P Lutz, D I Pinon, L K Gates, et al.
Zeitschrift Fur Gastroenterologie|October 26, 2006
[ASCO update 2006--highlights of the 42. meeting of the American Society of Clinical Oncology/ASCO 2006]A Reinacher-Schick, D Arnold, F Lordick, et al.
Cancer Research|August 29, 1998
Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cellsB B Flossmann-Kast, P M Jehle, A Hoeflich, et al.
Cancer Research|April 20, 2001
Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell linesA Menke, C Philippi, R Vogelmann, et al.
The American Journal of Physiology|January 22, 1998
Protein tyrosine phosphorylation in pancreatic acini: differential effects of VIP and CCKM P Lutz, A Piiper, H Y Gaisano, et al.
Zeitschrift Fur Gastroenterologie|October 17, 2003
[ASCO Update 2003 - Highlights of the 39th Meeting of the American Society of Clinical Oncology/ASCO 2003]T Eberl, U Graeven, M Heike, et al.
Zeitschrift Fur Gastroenterologie|December 14, 2004
[ASCO update -- highlights of the 40th Meeting of the American Society of Clinical Oncology/ASCO 2004]U Graeven, M Heike, T Höhler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinomaG Folprecht, M P Lutz, P Schöffski, et al.
Zeitschrift Fur Gastroenterologie|November 5, 1999
A phase II study of weekly 24-h infusion of high-dose 5-fluorouracil in advanced pancreatic cancerM P Lutz, M Königer, R Muche, et al.
Pageof 6